Cases & Deals

  • Home
  • Practices
  • Foundation Fournier-Majoie and xista science ventures co-lead €2 million seed financing of HEPHAISTOS-Pharma

Share

Foundation Fournier-Majoie and xista science ventures co-lead €2 million seed financing of HEPHAISTOS-Pharma

January 2024

Client(s) Foundation Fournier-Majoie and xista science ventures

Jones Day represented Foundation Fournier-Majoie and xista science ventures in connection with co-leading the €2 million seed financing of HEPHAISTOS-Pharma to industrialize its manufacturing process and prepare for the clinical phases, with the goal of advancing its lead candidate, ONCO-Boost, into clinical development for the treatment of solid tumors with high unmet medical needs, in particular sarcoma.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.